Leveraging AI-ECG Technology for Early Notification and Tracking of AF Development (LATENT): A Randomized Controlled Trial
Circulation · 07.11.2026
DOI: 10.1161/circulationaha.126.083540 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Circulation, online erschienen am 07.11.2026. Verfasst von Chiao-Chin Lee und 25 weiteren Autor:innen. Beteiligte Einrichtung: Divisions of Cardiology (C.-C.L., W.-Y.L., W.-T.L., C.-H.C., Y.-L.L., D.-W.C., P.-Y.L., W.-C.L., T.-C.L., H.-H.C., W.-S.L., C.-C.C., C.-S.L.), Nation…. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
BACKGROUND: Electrocardiographic analysis aided by artificial intelligence (AI) may identify atrial electrical vulnerability during sinus rhythm. The objective of this study was to determine whether AI–enabled ECG (AI-ECG) is effective for detecting atrial fibrillation (AF), atrial flutter (AFl), or prespecified pre-AF atrial findings in a randomized trial. METHODS: In this single-center, open-label trial, 14 665 adults 40 to 85 years of age without previous AF/AFl were randomized to an AI-ECG–guided strategy or usual care. Participants randomized to AI-ECG who were then identified by AI as having a high-risk sinus-rhythm ECG in the preceding year were offered Holter monitoring for ≤7 days. Each monitored high-risk intervention participant was paired with an age- and sex-matched control selected before control ECGs underwent AI analysis. Matched controls received identical monitoring to reduce ascertainment bias. Reporting cardiologists were blinded to AI results and randomized assignment. The primary outcome was a composite of newly detected AF, AFl, or pre-AF atrial findings within 90 days. Pre-AF atrial findings comprised frequent premature atrial complexes, short runs of premature atrial complexes, or nonsustained AF/AFl. RESULTS: Among 7337 intervention and 7328 control participants, 84 (1.1%) and 78 (1.1%), respectively, were classified as high risk. Of the 84 high-risk intervention participants, 48 (57.1%) underwent monitoring, as did 48 matched controls. The primary outcome occurred in 54 intervention participants (0.74%) versus 35 control participants (0.48%; odds ratio, 1.54 [95% CI, 1.01–2.37]; P =0.046). Hypothetical reclassification of 1 intervention event to a nonevent changed the primary analysis P value to 0.057. The intervention effect on detection of the primary composite outcome differed by baseline AI-ECG risk ( P interaction
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Divisions of Cardiology (C.-C.L., W.-Y.L., W.-T.L., C.-H.C., Y.-L.L., D.-W.C., P.-Y.L., W.-C.L., T.-C.L., H.-H.C., W.-S.L., C.-C.C., C.-S.L.), National Defense Medical University, Taipei, Taiwan, China.
- Tri-Service General Hospital, Graduate Institute of Medical Sciences (C.-C.L., Y.-L.L., D.-W.C., C.-S.L.), National Defense Medical University, Taipei, Taiwan, China.
- Military Digital Medical Center (Y.L., D.‑J.T., K.-C.C., C.L.), National Defense Medical University, Taipei, Taiwan, China.
- School of Medicine, College of Medicine (D.‑J.T., K.-C.C., C.L., C.-S.L.), National Defense Medical University, Taipei, Taiwan, China.
- Research Services Center for Health Information, Chang Gung University, Taoyuan, Taiwan, China (S.-C.C.).
- Department of Family and Community Medicine (W.-H.F.), National Defense Medical University, Taipei, Taiwan, China.
ORCID-Profile: Chiao-Chin Lee, Wen-Yu Lin, Wei-Ting Liu, Chiao-Hsiang Chang, Yu-Lan Liu, Da-Wei Chang, Pang-Yen Liu, YuChih Lin, Dung-Jang Tsai, Kai-Chieh Chen, Shu-Chen Chang, Wen-Hui Fang, Wei-Shiang Lin, Kuan-Hsun Lin, Chih-Yuan Lin, Yi-Ting Tsai, Chien-Sung Tsai, C-S Lin
Zitieren
APA
Lee, C. C., Lin, W. Y., Liu, W. T., Chang, C. H., Liu, Y. L., Chang, D. W., Liu, P. Y., Liu, W. C., Lin, Y., Tsai, D. J., Chen, K. C., Lin, T. C., Chang, S. C., Chen, H. H., Fang, W. H., Lin, W. S., Cheng, C. C., Lin, K. H., Chen, T. W., …, & Lin, C. S. (2026). Leveraging AI-ECG Technology for Early Notification and Tracking of AF Development (LATENT): A Randomized Controlled Trial. Circulation. https://doi.org/10.1161/circulationaha.126.083540
Vancouver
Lee CC, Lin WY, Liu WT, Chang CH, Liu YL, Chang DW, et al. Leveraging AI-ECG Technology for Early Notification and Tracking of AF Development (LATENT): A Randomized Controlled Trial. Circulation. 2026. doi:10.1161/circulationaha.126.083540
BibTeX
@article{Lee2026,
author = {Lee, Chiao-Chin and Lin, Wen-Yu and Liu, Wei-Ting and Chang, Chiao-Hsiang and Liu, Yu-Lan and Chang, Da-Wei and Liu, Pang-Yen and Liu, Wen-Cheng and Lin, YuChih and Tsai, Dung-Jang and Chen, Kai-Chieh and Lin, Tzu-Chiao and Chang, Shu-Chen and Chen, Hsin-Hui and Fang, Wen-Hui and Lin, Wei-Shiang and Cheng, Cheng-Chung and Lin, Kuan-Hsun and Chen, Teng-Wei and Lin, Chih-Yuan and Tsai, Yi-Ting and Chen, Yuan-Hao and Tsai, Chien-Sung and Lin, Shih-Hua and Lin, C and Lin, C-S},
title = {Leveraging AI-ECG Technology for Early Notification and Tracking of AF Development (LATENT): A Randomized Controlled Trial},
journal = {Circulation},
year = {2026},
doi = {10.1161/circulationaha.126.083540}
}
EUVIMED